{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T12:23:54Z","timestamp":1783686234849,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Plant Foods Hum Nutr"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s11130-026-01515-y","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T10:08:40Z","timestamp":1780394920000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of Broccoli Sprout Supplementation and Pilates Training on Liver Enzymes in Women with Nonalcoholic Fatty Liver Disease: A Double-Blind, Randomized Controlled Trial"],"prefix":"10.1007","volume":"81","author":[{"given":"Kimia","family":"Ghorbanian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negin","family":"Tavakoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parisa Saheb","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohre","family":"Amirkhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"1515_CR1","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S0140-6736(15)00803-X","volume":"387","author":"MJ Armstrong","year":"2016","unstructured":"Armstrong MJ, Gaunt P, Aithal GP, Barton D, Hull D, Parker R, Hazlehurst JM, Guo K, Abouda G, Aldersley MA, Stocken D, Gough SC, Tomlinson JW, Brown RM, H\u00fcbscher SG, Newsome PN (2016) Liraglutide safety and efficacy in patients with non\u2013alcoholic steatohepatitis (LEAN): a multicentre, double\u2013blind, randomised, placebo\u2013controlled phase 2 study. Lancet 387:679\u2013690. https:\/\/doi.org\/10.1016\/S0140-6736(15)00803-X","journal-title":"Lancet"},{"key":"1515_CR2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.37349\/emd.2020.00005","volume":"1","author":"NC Salvoza","year":"2020","unstructured":"Salvoza NC, Giraudi PJ, Tiribelli C, Rosso N (2020) Sex differences in non\u2013alcoholic fatty liver disease: hints for future management of the disease. Explor Med 1:51\u201374. https:\/\/doi.org\/10.37349\/emd.2020.00005","journal-title":"Explor Med"},{"issue":"1","key":"1515_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M (2016) Global epidemiology of nonalcoholic fatty liver disease\u2014Meta\u2013analytic assessment of prevalence, incidence, and outcomes. Hepatology 64(1):73\u201384. https:\/\/doi.org\/10.1002\/hep.28431","journal-title":"Hepatology"},{"issue":"8","key":"1515_CR4","doi-asserted-by":"publisher","first-page":"ePub","DOI":"10.18502\/ijph.v52i8.13399","volume":"52","author":"A Akbari Sari","year":"2023","unstructured":"Akbari Sari A, Olyaeemanesh A, Ostadtaghizadeh A, Pourmand MR, Shakibazadeh E, Shataheri SJ, Taghdisi MH (2023) The prevalence of non\u2013alcoholic fatty liver disease in Iranian children and adult population: a systematic review and meta\u2013analysis. Iran J Public Health 52(8):ePub. https:\/\/doi.org\/10.18502\/ijph.v52i8.13399","journal-title":"Iran J Public Health"},{"key":"1515_CR5","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12876-024-03302-y","volume":"24","author":"M AkbariRad","year":"2024","unstructured":"AkbariRad M, Pezeshki Rad M, Nobakht H et al (2024) Prevalence, characteristics, and risk factors of non\u2013alcoholic fatty liver disease in North East of Iran: a population\u2013based study. BMC Gastroenterol 24:212. https:\/\/doi.org\/10.1186\/s12876-024-03302-y","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"1515_CR6","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1007\/s12325-020-01279-9","volume":"37","author":"A Gillessen","year":"2020","unstructured":"Gillessen A, Schmidt HHJ (2020) Silymarin as supportive treatment in liver diseases: a narrative review. Adv Therapy 37(4):1279\u20131301. https:\/\/doi.org\/10.1007\/s12325-020-01279-9","journal-title":"Adv Therapy"},{"issue":"2","key":"1515_CR7","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s40200-023-01293-3","volume":"22","author":"C Mihai","year":"2023","unstructured":"Mihai C, Mihai B (2023) Unraveling the link between insulin resistance and non\u2013alcoholic fatty liver disease (or metabolic dysfunction\u2013associated steatotic liver disease): a narrative review. J Diabetes Metabolic Disorders 22(2):1083\u20131094. https:\/\/doi.org\/10.1007\/s40200-023-01293-3","journal-title":"J Diabetes Metabolic Disorders"},{"issue":"5","key":"1515_CR8","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1002\/hep.32602","volume":"77","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Neuschwander\u2013Tetri BA, Caldwell SH et al (2023) AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology 77(5):1797\u20131835. https:\/\/doi.org\/10.1002\/hep.32602","journal-title":"Hepatology"},{"issue":"22","key":"1515_CR9","first-page":"PMID38009414","volume":"15","author":"A Lari","year":"2023","unstructured":"Lari A, Sohouli MH, Fatahi S et al (2023) The effect of lifestyle interventions on metabolic syndrome components: a systematic review and meta\u2013analysis. Nutrients 15(22):PMID38009414. https:\/\/pubmed.ncbi.nlm.nih.gov\/38009414\/","journal-title":"Nutrients"},{"issue":"5","key":"1515_CR10","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.jhep.2022.06.006","volume":"77","author":"X Zhang","year":"2022","unstructured":"Zhang X, Zhang T, Li Q, Zhang S, Li J, Tang Y et al (2022) Exercise training in non\u2013alcoholic fatty liver disease: a systematic review and meta\u2013analysis. J Hepatol 77(5):1509\u20131523. https:\/\/doi.org\/10.1016\/j.jhep.2022.06.006","journal-title":"J Hepatol"},{"issue":"3","key":"1515_CR11","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1002\/hep.31122","volume":"72","author":"LA Orci","year":"2020","unstructured":"Orci LA, Gariani K, Oldani G, Delaune V, Morel P, Toso C (2020) Exercise\u2013based interventions for nonalcoholic fatty liver disease: a meta\u2013analysis and meta\u2013regression. Hepatology 72(3):1200\u20131211. https:\/\/doi.org\/10.1002\/hep.31122","journal-title":"Hepatology"},{"issue":"1","key":"1515_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jhep.2011.11.010","volume":"57","author":"SE Keating","year":"2012","unstructured":"Keating SE, Hackett DA, George J, Johnson NA (2012) Exercise and non\u2013alcoholic fatty liver disease: a systematic review and meta\u2013analysis. J Hepatol 57(1):157\u2013166. https:\/\/doi.org\/10.1016\/j.jhep.2011.11.010","journal-title":"J Hepatol"},{"issue":"5","key":"1515_CR13","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.clnu.2022.12.027","volume":"42","author":"Y Chen","year":"2023","unstructured":"Chen Y, Li L, Tang Y, Chen J, Xu M, Wang Y et al (2023) Effects of different exercise modalities on non\u2013alcoholic fatty liver disease: a systematic review and meta\u2013analysis. Clin Nutr 42(5):1034\u20131046. https:\/\/doi.org\/10.1016\/j.clnu.2022.12.027","journal-title":"Clin Nutr"},{"issue":"2","key":"1515_CR14","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jhep.2018.10.013","volume":"70","author":"K Hallsworth","year":"2019","unstructured":"Hallsworth K, Adams LA (2019) Lifestyle modification in NAFLD\/NASH: facts and figures. J Hepatol 70(2):353\u2013371. https:\/\/doi.org\/10.1016\/j.jhep.2018.10.013","journal-title":"J Hepatol"},{"key":"1515_CR15","doi-asserted-by":"publisher","unstructured":"Schepici G, Contestabile V, Santoro M, Bramanti P, Mazzon E (2020) Focus on the role of silymarin in the management of liver diseases: a review of the molecular mechanisms underlying its therapeutic effects. Evidence-Based Complement Altern Med 2020(8891534). https:\/\/doi.org\/10.1155\/2020\/8891534","DOI":"10.1155\/2020\/8891534"},{"issue":"8","key":"1515_CR16","doi-asserted-by":"publisher","first-page":"e13811","DOI":"10.1111\/jfbc.13811","volume":"45","author":"S Shukla","year":"2021","unstructured":"Shukla S, Paschal JW, Bajpai VK, Lee J, Vinayak SA (2021) Bioactive compounds of broccoli and their health benefits. J Food Biochem 45(8):e13811. https:\/\/doi.org\/10.1111\/jfbc.13811","journal-title":"J Food Biochem"},{"issue":"10","key":"1515_CR17","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.3390\/nu11102357","volume":"11","author":"AG Guggenheim","year":"2019","unstructured":"Guggenheim AG, Fahey JW (2019) Phytochemicals and cancer. Nutrients 11(10):2357. https:\/\/doi.org\/10.3390\/nu11102357","journal-title":"Nutrients"},{"issue":"4","key":"1515_CR18","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1021\/jf980985s","volume":"47","author":"MM Kushad","year":"1999","unstructured":"Kushad MM, Ciska E, Fahey JW, Williams RE, Loseto AS, Bj\u00f6rkman T (1999) Variation of glucosinolates in vegetable crops of Brassica oleracea. J Agric Food Chem 47(4):1541\u20131548. https:\/\/doi.org\/10.1021\/jf980985s","journal-title":"J Agric Food Chem"},{"key":"1515_CR19","doi-asserted-by":"publisher","first-page":"108643","DOI":"10.1016\/j.jnutbio.2021.108643","volume":"91","author":"S Wu","year":"2021","unstructured":"Wu S, Wang Y, Li Z (2021) Sulforaphane ameliorates non\u2013alcoholic fatty liver disease by inhibiting lipogenesis and oxidative stress via the Nrf2 pathway. J Nutr Biochem 91:108643. https:\/\/doi.org\/10.1016\/j.jnutbio.2021.108643","journal-title":"J Nutr Biochem"},{"issue":"3","key":"1515_CR20","doi-asserted-by":"publisher","first-page":"814","DOI":"10.3390\/nu12030814","volume":"12","author":"SH Park","year":"2020","unstructured":"Park SH, Kim JH, Kim HJ, Kim YH, Lee SA, Kim CH (2020) Sulforaphane inhibits hepatic lipogenesis and ameliorates hepatic steatosis in mice fed a high\u2013fat diet. Nutrients 12(3):814. https:\/\/doi.org\/10.3390\/nu12030814","journal-title":"Nutrients"},{"issue":"10","key":"1515_CR21","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1089\/ars.2010.3278","volume":"14","author":"JD Clarke","year":"2011","unstructured":"Clarke JD, Dashwood RH, Ho CT (2011) Multi\u2013targeted cancer prevention through induction of phase II and reduction of procarcinogenic phase I enzymes: recent results with compounds derived from coffee, cruciferous vegetables, and dietary herbs. Antioxid Redox Signal 14(10):1951\u20131969. https:\/\/doi.org\/10.1089\/ars.2010.3278","journal-title":"Antioxid Redox Signal"},{"issue":"4","key":"1515_CR22","doi-asserted-by":"publisher","first-page":"510","DOI":"10.3945\/an.116.013771","volume":"8","author":"Z Bahadoran","year":"2017","unstructured":"Bahadoran Z, Mirmiran P, Azizi F (2017) Broccoli sprouts: a preserver of human health. Adv Nutr 8(4):510\u2013519. https:\/\/doi.org\/10.3945\/an.116.013771","journal-title":"Adv Nutr"},{"key":"1515_CR23","doi-asserted-by":"publisher","first-page":"101070","DOI":"10.1016\/j.redox.2019.101070","volume":"21","author":"J Xu","year":"2019","unstructured":"Xu J, Kulkarni SR, Donepudi AC, More VR, Slitt AL (2019) Sulforaphane induces Nrf2\u2013dependent autophagy and protects against hepatic steatosis. Redox Biol 21:101070. https:\/\/doi.org\/10.1016\/j.redox.2019.101070","journal-title":"Redox Biol"},{"key":"1515_CR24","doi-asserted-by":"publisher","first-page":"695906","DOI":"10.3389\/fphar.2021.695906","volume":"12","author":"MJ Lee","year":"2021","unstructured":"Lee MJ, Balaraman MA, Yeo EJ (2021) Sulforaphane: a potent Nrf2 activator with multiple effects on cardiovascular and metabolic diseases. Front Pharmacol 12:695906. https:\/\/doi.org\/10.3389\/fphar.2021.695906","journal-title":"Front Pharmacol"},{"issue":"17","key":"1515_CR25","doi-asserted-by":"publisher","first-page":"3831","DOI":"10.1021\/acs.jafc.8b00416","volume":"66","author":"JL Yao","year":"2018","unstructured":"Yao JL, He J, Zhang Y, Chen T, Zhang H, Gao Y, Chen J, Xu X (2018) Sulforaphane alleviates non\u2013alcoholic fatty liver disease by activating the Nrf2 pathway in mice. J Agric Food Chem 66(17):3831\u20133843. https:\/\/doi.org\/10.1021\/acs.jafc.8b00416","journal-title":"J Agric Food Chem"},{"issue":"16","key":"1515_CR26","first-page":"102","volume":"8","author":"S Beigi","year":"2020","unstructured":"Beigi S, Khajehlandi M, Golestani F (2020) Effects of aerobic\u2013pilates exercise training on serum levels of liver enzymes and sonography of patients with non\u2013alcoholic fatty liver disease. J Practical Stud Biosci Sports 8(16):102\u2013115 (in Persian)","journal-title":"J Practical Stud Biosci Sports"},{"issue":"3","key":"1515_CR27","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1158\/1940-6207.CAPR-10-0296","volume":"4","author":"PA Egner","year":"2011","unstructured":"Egner PA, Chen JG, Wang JB, Wu Y, Sun Y, Lu JH, Zhu J, Zhang YH, Chen TY, Fahey JW, Talalay P, Kensler TW (2011) Bioavailability of glucoraphanin and sulforaphane from broccoli sprouts: influence of processing methods and gut microflora. Cancer Prev Res (Philadelphia) 4(3):384\u2013395. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-10-0296","journal-title":"Cancer Prev Res (Philadelphia)"},{"issue":"1","key":"1515_CR28","doi-asserted-by":"publisher","first-page":"1800889","DOI":"10.1002\/mnfr.201800889","volume":"63","author":"JW Fahey","year":"2019","unstructured":"Fahey JW, Holtzclaw WD, Wehage SL, Wade KL, Stephenson KK, Talalay P (2019) Clinical applications for broccoli sprout phytochemicals: sulforaphane and glucoraphanin. Mol Nutr Food Res 63(1):1800889. https:\/\/doi.org\/10.1002\/mnfr.201800889","journal-title":"Mol Nutr Food Res"},{"issue":"6","key":"1515_CR29","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1002\/ptr.7356","volume":"36","author":"SM Tan","year":"2022","unstructured":"Tan SM, de Souza RJ, Madsen KL, Meyre D, Leiter LA, Kendall CWC, Jenkins DJA, Sievenpiper JL (2022) The effects of sulforaphane supplementation on metabolic health: a systematic review of randomized controlled trials. Phytother Res 36(6):2363\u20132376. https:\/\/doi.org\/10.1002\/ptr.7356","journal-title":"Phytother Res"},{"issue":"5","key":"1515_CR30","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1158\/1055-9965.EPI-05-0863","volume":"15","author":"TA Shapiro","year":"2006","unstructured":"Shapiro TA, Fahey JW, Wade KL, Stephenson KK, Talalay P (2006) Human metabolism and excretion of cancer chemoprotective glucosinolates and isothiocyanates of cruciferous vegetables. Cancer Epidemiol Biomarkers Prev 15(5):915\u2013920. https:\/\/doi.org\/10.1158\/1055-9965.EPI-05-0863","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1515_CR31","doi-asserted-by":"publisher","first-page":"k2173","DOI":"10.1136\/bmj.k2173","volume":"361","author":"JM Ordovas","year":"2018","unstructured":"Ordovas JM, Ferguson LR, Tai ES, Mathers JC (2018) Personalised nutrition and health. BMJ 361:k2173. https:\/\/doi.org\/10.1136\/bmj.k2173","journal-title":"BMJ"}],"container-title":["Plant Foods for Human Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11130-026-01515-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11130-026-01515-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11130-026-01515-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T12:09:05Z","timestamp":1783685345000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11130-026-01515-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1515"],"URL":"https:\/\/doi.org\/10.1007\/s11130-026-01515-y","relation":{},"ISSN":["0921-9668","1573-9104"],"issn-type":[{"value":"0921-9668","type":"print"},{"value":"1573-9104","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"30 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Islamic Azad University of Mashhad (IR.IAU.MSHD.REC.1402.134). Written informed consent was obtained from all participants prior to enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"72"}}